Skip to main content

DNAVision, BioXpr Integrate Genetic Analysis, Informatics

NEW YORK (GenomeWeb News) – DNAVision said today that it has teamed with BioXpr to offer an integrated genetic analysis and bioinformatics platform.

The company said that the offering will cover design, experimentation, analysis, and interpretation of microarray-based research projects focused on drug discovery and development.

BioXpr, a spin-off from Namur University in Belgium, offers bioinformatics solutions used in collecting, storing, extracting, and analyzing data from high-throughput experiments, clinical trials, databases, and literature. DNAVision offers a range of services and technologies, including nucleic acids extraction, expression profiling, SNP genotyping, and DNA sequencing.

BioXpr CEO Benjamin Damien said in a statement that the platform "will create an ideal environment to easily integrate genomics data into systems biology."

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.